Zobrazeno 81 - 90
of 64 945
pro vyhledávání: ''
Autor:
Audrey Rambeau, Elodie Vauleon, Marion Perréard, Emeline Guiard, Alison Claire Johnson, Caroline Even, Cyril Abdeddaim, Florian Clatot
Publikováno v:
European Journal of Cancer. 159:125-132
Background Immune checkpoint inhibitors are widely used in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). We aimed to describe response rates to taxanes after progression on nivolumab in R/M HNSCC patients. Methods In
Autor:
Driele Peixoto, Renata Colombo Bonadio, Juliana Pereira, Odeli Nicole Encinas Sejas, Camilla Hoff, Vanderson Rocha, Gabriel Y. Watarai, Veruska Menegatti Anastacio, Camila Motta Venchiarutti Moniz, Lorena Teixeira Frasson, Edson Abdala, Raquel Keiko de Luca Ito, Guilherme Nader Marta, Maria Del Pilar Estevez-Diz, Maria Cecilia Mathias Machado, Paulo M. Hoff, Ulysses Ribeiro
Publikováno v:
JCO Global Oncology
PURPOSE Patients with cancer are at increased risk for unfavorable outcomes from COVID-19. Knowledge about the outcome determinants of severe acute respiratory syndrome coronavirus 2 infection in this population is essential for risk stratification a
Autor:
Yoshiaki Murakami, Shingo Seo, Hiroyuki Otsuka, Yasushi Hashimoto, Naru Kondo, Shinya Takahashi, Takeshi Sudo, Kenjiro Okada, Tatsuaki Sumiyoshi, Kenichiro Uemura
Publikováno v:
European Journal of Cancer. 159:215-223
Background The prognosis of patients with borderline resectable pancreatic cancer with arterial contact (BRPC-A) is extremely poor, and effective preoperative treatment is indispensable. We evaluated the clinical efficacy and safety of neoadjuvant ch
Autor:
Gyungyub Gong, Min Jeong Song, Kyung-Ja Cho, Ji-Seon Jeong, Yong Mee Cho, Uiree Jo, Joon Seon Song
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8899-8908 (2021)
Cancer Medicine
Cancer Medicine
Introduction A pericardial effusion (PE) has a variable etiology and the primary role is diagnosis of metastatic malignancy. We analyzed the PE cytology in a large cohort in accordance with the international system for reporting serous fluid cytopath
Autor:
Melissa A. Troester, Lynn Rosenberg, Leslie Bernstein, Kimberly A. Bertrand, Christine B. Ambrosone, Ludovic Trinquart, Ruth M. Pfeiffer, Elisa V. Bandera, Tracy A. Battaglia, Gary Zirpoli, Julie R. Palmer
Publikováno v:
J Clin Oncol
PURPOSE Breast cancer risk prediction models are used to identify high-risk women for early detection, targeted interventions, and enrollment into prevention trials. We sought to develop and evaluate a risk prediction model for breast cancer in US Bl
Autor:
Márcia Datz Abadi, Paula de Mendonça Batista, Rodrigo Buzzatti Peixoto, Carlos Gil Ferreira, Erica Regina Cerqueira, Lucas Miyake Okumura, Fernando Brandão Serra
Publikováno v:
JCO Global Oncology
PURPOSE Non–small-cell lung cancer (NSCLC) is the most common type of lung cancer and accounts for 80%-90% of the cases. In Brazil, between 2018 and 2019, lung cancer was ranked as the second most frequent cancer among men and the fourth among wome
Autor:
Neal D. Shore, Joyce Steinberg, Bertrand Tombal, Ugo De Giorgi, Xun Lin, Qi Shen, Fred Saad, David F. Penson, Katarzyna Madziarska, Jennifer Sugg, Cora N. Sternberg, Eleni Efstathiou, Maha Hussain, Karim Fizazi
Publikováno v:
European journal of cancer, Vol. 159, p. 237-246 (2021)
BACKGROUND: Enzalutamide combined with androgen deprivation therapy (ADT) significantly prolonged metastasis-free survival and overall survival (OS) versus ADT alone in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) with r
Publikováno v:
Future Oncology. 17:5067-5075
Aim: To compare anticholinergic burden (ACB) in older patients with and without cancer and evaluate the effects of ACB on geriatric syndromes. Methods: A total of 291 patients from the geriatric clinic and 301 patients from the oncology clinic were e
Autor:
Li Pang, Zhiqiang Guo
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8558-8569 (2021)
Cancer Medicine
Cancer Medicine
Background There is currently no recognized first‐line treatment strategy for ovarian neuroendocrine tumors (NETs). Furthermore, because of the low incidence of ovarian NETs, no studies have reported prognostic statistics derived from large samples
Autor:
Daniel A. Pollyea, Anagha Inguva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:805-811
The use of venetoclax in combination with hypomethylating agents (HMA) has changed the paradigm for the treatment of acute myeloid leukemia (AML) in elderly patients and those unfit for intensive chemotherapy. A phase 3 study has shown superior respo